RxSight, Inc. (RXST) financial statements and ratios from SEC XBRL: revenue $0.1B (TTM), net margin -29.0%, revenue growth -18.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $134.48M |
| Revenue (TTM) | $0.1B |
| Net Margin | -29.0% |
| Operating Margin (TTM) | -43.4% |
| Revenue Growth (YoY) | -18.5% |
| EPS Growth (YoY) | 90.0% |
| FCF Growth (YoY) | 23.8% |
| Price / Book | 1.09 |
| Price / Sales | 2.29 |
| FCF Yield | -6.6% |
| Altman Z-Score | 2.76 (grey) |
| Industry P/E (Medical Equipment) | 29.8 |
| Sector P/E (Healthcare) | 21.6 |
RXST overview · RXST earnings · RXST KPIs · RXST documents · RXST ownership · RXST peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.